The PreDx Diabetes Risk Score (DRS) is a first-of-its-kind predictive blood test that measures multiple biomarkers linked to critical biological pathways implicated in the development of diabetes. The PreDx DRS reclassifies a vast “at-risk” diabetes population (currently 57 million) into more clearly differentiated risk categories, and identifies those individuals at highest risk of developing diabetes within the next 5 years.

Combining ease-of-use with enhanced risk stratification, the PreDx Diabetes Risk Score provides new information that can help guide the development of optimal diabetes prevention plans targeted to individuals at highest risk of converting to diabetes within 5 years. As such, it is a valuable new tool for clinicians striving to address the escalating diabetes epidemic within their own practices.

For more information please visit www.tethysbio.com

5858 Horton Street, Suite 550, Emeryville, California 94608
Direct: (510) 420-6700
Toll Free: (888) 697-7339
Fax: (510) 601-0371
clientservices@tethysbio.com